PharmaCyte Biotech Inc (PMCB)

[longboarder7892]

The first-ever blood test for pancreatic cancer This could be a big win for PMCB (pancreatic adenocarcinoma) is now available for people considered high risk for the disease due to family history or genetic alterations.

Immunovia Inc.'s IMMray® PanCan-d test can potentially detect pancreatic cancer before it causes symptoms or is diagnosed through other methods. The test does not provide a definitive diagnosis and is not a standalone indicator of the presence of pancreatic cancer.

Read more about Immunovia Inc.'s IMMray PanCan-d Test.

PanCAN Patient Services is here to provide free information and answer questions about the blood test, as well as discuss other ways to detect and diagnose pancreatic cancer.

Diagnosing pancreatic cancer in its earlier stages can lead to more treatment options, including surgery, and better survival.

PanCAN is working on progress in early detection research, including our Early Detection Initiative, announced in April this year. Immunovia Inc.'s IMMray PanCan-d test can be another important step toward more patients being diagnosed earlier.

If you are considered high risk for developing pancreatic cancer, contact PanCAN Patient Services regarding next steps, including speaking with your doctor about whether the new blood test may be right for you.